Cancer Diagnosis
16
7
7
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
0.0%
0 terminated out of 16 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
40%
2 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (16)
PRISM for Depression and Anxiety in Young Adults With Cancer
Building Resiliency Among Caregivers of Curvivors and Metavivors
Avera Cancer Sequencing and Analytics Protocol (ASAP)
Evaluation of Multi-Cancer Early Detection Testing in a High-Risk Military Population: The Sentinel Study
Digital Solutions for bEtter cAre
The DISCOVER Study
STEpwise Research Program to Promote INGeniouS ONline Supportive Solutions in the Relief of Cancer-related Fatigue
Clinical Validation of Immunovia Next-Generation Blood Biomarker Test to Detect Early-Stage Pancreatic Cancer
Raman Spectroscopy-Based Deep Learning Model for Early Pan-Cancer Early Diagnosis
Multi-methods Study on Inclusive Cancer Diagnosis in People with Disabilities and Health Outcomes
Hyperpolarized MR Imaging with Carbon-13 Pyruvate in the Human Body
Prospective Screening and Differentiating Common Cancers Using Peripheral Blood Cell-Free DNA Sequencing
Cancer Survivors and Their Romantic Partners' Preferences for a Couples-based Physical Activity
Real-time Diagnosis and Visualization of Tumor Margins in Excised Breast Specimens Using Zenith FLIM Diagnostics
Comparison of PET/CT vs. PET/MRI Using 2 Radiopharmaceuticals
Prospective Evaluation of Efficacy and Safety of Fondaparinux in Surgical Cancer Patients, Risk Factors for Thromboembolism